MENU
  • Magazine
  • Facebook
  • Twitter
Cancer World Archive
  • Magazine
HomeImpact FactorThe ROC ‘n’ role of the multiplex assay for early detection of ovarian cancer

The ROC ‘n’ role of the multiplex assay for early detection of ovarian cancer

Alpa Nick and Anil Sood

1 November 2008 Impact Factor 0

Number 27

Download pdf article

The sensitivity and specificity of CA125 for early detection of ovarian cancer is improved when analysed in combination with novel biomarkers, although further validation studies are required to confirm the clinical utility of the multiplex assay.

Download full article

  • CA125
  • ovarian cancer
  • ovarian cancer screening
Previous article
Next article

Related Articles

CancerWorld Plus

How to nurse hope in recurrent ovarian cancer

CancerWorld Plus, Featured 2 September 2019 0
No Picture
Impact Factor

Should patients with ovarian cancer receive intraperitoneal chemotherapy following initial cytoreductive surgery?

Impact Factor 1 November 2006 0
Featured

Hereditary mutations in cancer: the use of panels and genetic counselling

Featured, Grandround 25 May 2018 0

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy